1 / 9

In Vitro Diagnostics (IVD) Asia-Pacific Market Research Report, 2014 - 2020

In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. The overall revenue of the Asia-Pacific IVD market accounted for about $10.7 billion in 2014, and is estimated to reach $15.3 billion by 2020, registering a CAGR of 6.5% over the forecast period. <br><br>To know more visit us @ http://www.apacmarket.com/top-market/apac-in-vitro-diagnostics-market<br>

apacmarket
Download Presentation

In Vitro Diagnostics (IVD) Asia-Pacific Market Research Report, 2014 - 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. In Vitro Diagnostics (IVD) Asia-Pacific Market Research Report 2014-2020 Published Date: 31-Jul-2015 No. Pages : 180

  2. Report Description In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. The overall revenue of the Asia-Pacific IVD market accounted for about $10.7 billion in 2014, and is estimated to reach $15.3 billion by 2020, registering a CAGR of 6.5% over the forecast period. Considerable increase in the number of chronic and infectious diseases, growing awareness towards healthcare solutions and technological advancements in healthcare industry largely supplement the growth of this market. However, stringent regulatory policies and reimbursements issues in few countries limit the growth of this market. The rising demand for technologically advanced diagnostic devices, rise in GDP and per capita income and rise in disposable incomes facilitate a huge potential for the IVD market in the Asia-Pacific region. The Asia-Pacific IVD market is segmented based on technique, product type, usability, application, end user and country. 

  3. Report Description Based on technique, the market is segmented into immunoassays, clinical chemistry, point-of-care, molecular diagnostics, hematology, coagulation, microbiology and other clinical techniques. Point-of-care is the highest revenue-generating segment in the overall IVD techniques market. However, the molecular diagnostics is the fastest growing technique in the overall IVD techniques market due to its ability to accurately detect the primary cause of the disease. Based on product type, the market is segmented into instruments, reagents, data management systems and services. Instruments segment holds the highest market share in the Asia-Pacific IVD market followed by rapidly growing reagents segment. Reagents are largely used in various equipment and play a key role in the overall diagnosis process. The usability segment is classified as disposable and reusable IVD devices.

  4. Report Description Doctors and clinicians largely prefer disposable devices to avoid infections; generating larger revenue in comparison to reusable devices. The application segment is categorized into infectious diseases diabetes, cancer/oncology, cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. Infectious diseases was the highest revenue-generating segment in 2014 and would continue to maintain its position throughout 2020, due to the rise in incidences of infectious diseases.  Hospitals and laboratories, academics, point-of-care testing and others form the end users segment in the Asia-Pacific IVD market. Hospitals and laboratories generate the highest revenue, followed by point-of-care. A significant rise in the number of hospitals and laboratories across the Asia-Pacific region along with increased awareness about developments in healthcare largely contribute to the growth of this segment.

  5. Key Market Benefits • Extensive coverage of the Asia-Pacific IVD market including drivers, restraints and opportunities would help professionals to better understand the market behavior • The projections in the report are made by analyzing the current market trends and market potential for the period of 2014–2020 • A comprehensive analysis of the market scenario in terms of technologies, applications, usability, product type end users and geography helps identify the growth opportunities in the Asia-Pacific IVD market  • Key market players within the Asia-Pacific IVD market are profiled in the report and their strategies are analysed thoroughly, which helps in understanding competitive outlook of this market 

  6. Key Market Segments by Instruments

  7. IVF Market – by Geography China Australia India Japan Other

  8. Table of Contents Chapter 1    Introduction Chapter 2    Executive Summary Chapter 3    Market Overview Chapter 4    Asia Pacific IVD Market, by Techniques Chapter 5    Asia Pacific IVD Market, by Product Type Chapter 6    Asia Pacific IVD Market, by Usability Chapter 7     Asia Pacific IVD Market, by Application Chapter 8     Asia Pacific IVD Market, by End-users Chapter 9     Asia Pacific IVD Market, by Countries

  9. FOR MORE DETAILS Visit us at : http://www.apacmarket.com/top-market/apac-in-vitro-diagnostics-market Stay With Us: • TELEPHONE: +61-280 454 214 • EMAIL:  help@apacmarket.com

More Related